Detalhe da pesquisa
1.
High Expression Levels of miR-21-5p in Younger Hospitalized COVID-19 Patients Are Associated with Mortality and Critical Disease.
Int J Mol Sci
; 24(12)2023 Jun 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37373259
2.
Expression of Surfactant Protein D Distinguishes Severe Pandemic Influenza A(H1N1) from Coronavirus Disease 2019.
J Infect Dis
; 224(1): 21-30, 2021 07 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33668070
3.
Lung microbiome alterations in patients with anti-Jo1 antisynthetase syndrome and interstitial lung disease.
Front Cell Infect Microbiol
; 13: 1321315, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38116136
4.
SARS-CoV-2 Direct Detection Without RNA Isolation With Loop-Mediated Isothermal Amplification (LAMP) and CRISPR-Cas12.
Front Med (Lausanne)
; 8: 627679, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33681254
5.
Corrigendum: CXCL17 Is a Specific Diagnostic Biomarker for Severe Pandemic Influenza A(H1N1) That Predicts Poor Clinical Outcome.
Front Immunol
; 12: 700716, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34054884
6.
Clinical and Immunological Factors That Distinguish COVID-19 From Pandemic Influenza A(H1N1).
Front Immunol
; 12: 593595, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33995342
7.
CXCL17 Is a Specific Diagnostic Biomarker for Severe Pandemic Influenza A(H1N1) That Predicts Poor Clinical Outcome.
Front Immunol
; 12: 633297, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33717172